Find uplifting stories about heroes, innovations, and solutions
81 results for "personalized medicine"
A groundbreaking study shows personalized mRNA vaccines combined with immunotherapy kept nearly 70% of melanoma patients cancer-free after five years, compared to just 49% with immunotherapy alone. The same technology that powered COVID-19 vaccines is now transforming how we fight cancer.
A new combination therapy for aggressive prostate cancer just got FDA approval, along with two tests that help doctors match the right patients to this targeted treatment. This breakthrough could help up to 30% of men with advanced prostate cancer find a treatment plan designed specifically for their genes.
After nearly a decade on the same anxiety medication, former pageant titleholder Madeline Bohlman discovered a genetic test that changed everything. The GeneSight test revealed how her DNA affects medication response, leading to treatment that finally worked.
A groundbreaking gene test can now identify breast cancer patients who can safely skip chemotherapy, sparing two-thirds of people from brutal side effects while maintaining excellent survival rates. Over 5,000 NHS patients annually could avoid the harsh treatment thanks to this breakthrough.
A groundbreaking genomic test can now identify which breast cancer patients can safely skip chemotherapy, sparing millions from grueling side effects. The international trial shows hormone therapy alone works just as well for many patients.
Scientists have tested a surprising new approach to treating depression by targeting inflammation instead of brain chemicals alone. In a small UK trial, an arthritis drug helped 54% of patients with hard-to-treat depression achieve remission.
A newly approved ALS treatment can now target specific genetic causes of the disease, offering hope to patients with Lou Gehrig's disease. The FDA fast-tracked the therapy, marking a significant breakthrough in personalized medicine for neurological conditions.
A breakthrough genomic test allowed two-thirds of breast cancer patients to safely skip chemotherapy while maintaining the same survival rates. Medical innovations presented at this year's ASCO meeting could transform how doctors treat multiple cancer types.
After decades of research, personalized medicine has arrived with treatments that once seemed impossible. New diabetes drugs, RSV vaccines, and cancer screening advances are transforming patient care right now.
Researchers discovered a breakthrough biomarker that helps doctors predict which children with hard-to-treat cancers will respond to advanced therapy. The finding could transform how doctors personalize treatment for kids facing relapsed cancers.
Scientists have developed an AI system that reads bone marrow slides to match multiple myeloma patients with the treatments most likely to work for them. The breakthrough could help doctors personalize cancer care and spare patients from harsh therapies they don't need.
Scientists discovered that a DNA repair protein gone overactive damages cells just like BRCA mutations, potentially allowing thousands more cancer patients to access gentler, targeted treatments. The finding could expand personalized cancer care to patients who previously had limited options.
Andrew Satterlee survived brain cancer at 20, but doctors couldn't agree on which drugs to use. Now he's developed a platform that tests treatments on living tumor samples in just four days.
A personalized vaccine safely triggered immune responses in patients with glioblastoma, one of the most aggressive brain cancers. The early trial offers fresh hope for a disease that typically gives patients less than 18 months to live.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, doubled survival rates in early trials and kept one patient cancer-free for nearly five years. The vaccine trains each patient's immune system to recognize up to 40 unique cancer proteins, making it harder for tumors to hide.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, helped patients live twice as long as usual in a groundbreaking trial. One patient remains cancer-free nearly five years later.
A Yale scientist is discovering why some patients with myasthenia gravis don't improve with standard treatments, opening doors to personalized therapies. Her groundbreaking work could help doctors match the right medicine to each patient's unique disease pattern.
The FDA just created a faster pathway for patients with rare genetic disorders to access personalized gene therapies without lengthy clinical trials. While some experts celebrate this breakthrough for desperately ill patients, others urge caution about adequate safety monitoring.
University of Miami researchers discovered why immunotherapy works for some mesothelioma patients but not others, opening the door to personalized treatment. A simple blood test could soon tell doctors which patients will respond best.
Every single patient in a groundbreaking bowel cancer trial remains cancer-free nearly three years after treatment, flipping the script on standard care. The experimental immunotherapy worked so well that more than half showed no cancer by surgery.
Showing 20 of 81